title: Lenalidomide-associated pneumonitis in patients with plasma cell dyscrasias.
authors.affiliation: Department of Clinical and Therapeutics, Alexandra Hospital, School of Medicine, University of Athens, Greece.
authors.forename: Flora
authors.initials: F
authors.lastname: Zagouri
authors.forename: Maria
authors.initials: M
authors.lastname: Roussou
authors.forename: Efstathios
authors.initials: E
authors.lastname: Kastritis
authors.forename: Andreas
authors.initials: A
authors.lastname: Koureas
authors.forename: Eleni
authors.initials: E
authors.lastname: Tsokou
authors.forename: Magdalini
authors.initials: M
authors.lastname: Migkou
authors.forename: Maria
authors.initials: M
authors.lastname: Gavriatopoulou
authors.forename: Nikitas
authors.initials: N
authors.lastname: Nikitas
authors.forename: Maria
authors.initials: M
authors.lastname: Gkotzamanidou
authors.forename: Evangelos
authors.initials: E
authors.lastname: Terpos
authors.forename: Meletios-Athanasios
authors.initials: MA
authors.lastname: Dimopoulos
mesh_terms: D000368:Aged; D000818:Animals; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use; D000077269:Lenalidomide; D008297:Male; D051379:Mice; D008875:Middle Aged; D010265:Paraproteinemias / Q000188:drug therapy*; D011014:Pneumonia / Q000139:chemically induced* / Q000628:therapy; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D007155:Immunologic Factors; D013792:Thalidomide; D000077269:Lenalidomide